The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
Inside the Latest Version of NIST’s Cybersecurity Framework
Stephen Quinn discussed how the Cybersecurity Framework 2.0 can enhance cybersecurity governance and prepare for the future.
9m watch -
Former Energy CIO Examines Evolving Tech Priorities
Ann Dunkin discussed challenges in acquisition that impact how agencies can approach federal technology strategies and efficiencies.
14m listen -
Inside the DOGE Caucus' Fight Against Government Waste
Co-Chair Rep. Pete Sessions discussed the tech strategies to enhance operational efficiency at federal agencies.
17m listen -
HIMSS: AI Revolutionizes Federal Health Services
NTT Data’s Noel Hara shares insights on AI, efficiency and innovation in IT strategy and healthcare outcomes.
8m watch